INTEGRATED BIOPHARMA INC (INBP) › Gross ProfitINTEGRATED BIOPHARMA INC (INBP) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $10.16M2012: $7.61M2013: $5.50M2014: $4.88M2015: $4.39M2016: $5.50M2017: $6.67M2018: $4.99M2019: $6.22M2020: $6.73M2021: $9.48M2022: $6.55M2023: $4.06M2024: $3.88M2025: $5.56M$5.56M2011Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$5.56M+43.2%2024$3.88M-4.4%2023$4.06M-38.0%2022$6.55M-30.9%2021$9.48M+40.9%2020$6.73M+8.1%2019$6.22M+24.7%2018$4.99M-25.2%2017$6.67M+21.1%2016$5.50M+25.3%2015$4.39M-10.0%2014$4.88M-11.2%2013$5.50M-27.7%2012$7.61M-25.1%2011$10.16M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share